These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11587629)

  • 21. The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan.
    Global HIV/AIDS Vaccine Enterprise
    PLoS Med; 2005 Feb; 2(2):e25. PubMed ID: 15740411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine approaches currently in development.
    Gold D
    Body Posit; 1998 Jul; 11(7):34-5. PubMed ID: 11365616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV vaccine efficacy trials: A brief history, and options for going forward.
    McKinnon LR; Card CM;
    AIDS Rev; 2010; 12(4):209-17. PubMed ID: 21179185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral AIDS vaccine used in Thailand.
    AIDS Patient Care STDS; 2007 Nov; 21(11):894. PubMed ID: 18338436
    [No Abstract]   [Full Text] [Related]  

  • 25. HIV infections: the global epidemiology and goals for vaccine research.
    Ippolito G; Rezza G; Girardi E; Malkovsky M; Cairns JS
    Mol Med; 2000 Feb; 6(2):69-85. PubMed ID: 10859024
    [No Abstract]   [Full Text] [Related]  

  • 26. Primate models of AIDS vaccine development.
    Lamb-Wharton RJ; Joag SV; Stephens EB; Narayan O
    AIDS; 1997; 11 Suppl A():S121-6. PubMed ID: 9451975
    [No Abstract]   [Full Text] [Related]  

  • 27. Medicine. The need for a global HIV vaccine enterprise.
    Klausner RD; Fauci AS; Corey L; Nabel GJ; Gayle H; Berkley S; Haynes BF; Baltimore D; Collins C; Douglas RG; Esparza J; Francis DP; Ganguly NK; Gerberding JL; Johnston MI; Kazatchkine MD; McMichael AJ; Makgoba MW; Pantaleo G; Piot P; Shao Y; Tramont E; Varmus H; Wasserheit JN
    Science; 2003 Jun; 300(5628):2036-9. PubMed ID: 12829768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The global HIV vaccine enterprise.
    Esparza J
    Int Microbiol; 2005 Jun; 8(2):93-101. PubMed ID: 16052457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why don't we have an HIV/AIDS vaccine? When will we have one?
    Miramontes HM
    J Assoc Nurses AIDS Care; 1998; 9(3):95-7. PubMed ID: 9589425
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccine news is disappointing.
    AIDS Patient Care STDS; 2004 Apr; 18(4):253. PubMed ID: 15154413
    [No Abstract]   [Full Text] [Related]  

  • 31. Ozonation of human HIV-infected plasmas for producing a global vaccine: How HIV-patients may help fight the HIV pandemia.
    Bocci V; Zanardi I; Travagli V
    Virulence; 2010; 1(3):215-7. PubMed ID: 21178445
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Funding support lacking in search for HIV vaccine.
    AIDS Alert; 1999 Jan; 14(1):5-7. PubMed ID: 11366091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An HIV/AIDS vaccine: where do we go from here?
    Bernstein A
    Trends Microbiol; 2008 Dec; 16(12):553-4. PubMed ID: 18964019
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV-1 subtypes: implications for epidemiology, pathogenicity, vaccines and diagnostics. Workshop Report from the European Commission (DG XII, INCO-DC) and the Joint United Nations Programme on HIV/AIDS.
    AIDS; 1997 Dec; 11(15):17-36. PubMed ID: 9412719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obstacles and progress toward development of a preventive HIV vaccine.
    Heyward WL; MacQueen KM; Jaffe HW
    J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):28-34. PubMed ID: 11364630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies for an HIV vaccine.
    Letvin NL
    J Clin Invest; 2002 Jul; 110(1):15-20. PubMed ID: 12093882
    [No Abstract]   [Full Text] [Related]  

  • 37. Development of vaccination strategies that elicit broadly neutralizing antibodies against human immunodeficiency virus type 1 in both the mucosal and systemic immune compartments.
    Hone DM; DeVico AL; Fouts TR; Onyabe DY; Agwale SM; Wambebe CO; Blattner WA; Gallo RC; Lewis GK
    J Hum Virol; 2002; 5(1):17-23. PubMed ID: 12352264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perspectives for a protective HIV-1 vaccine.
    Schiavone M; Quinto I; Scala G
    Adv Pharmacol; 2008; 56():423-52. PubMed ID: 18086420
    [No Abstract]   [Full Text] [Related]  

  • 39. AIDS vaccine: efficacy, safety and ethics.
    Veljkovic V; Veljkovic N; Glisic S; Ho MW
    Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccine to prevent AIDS.
    Tyring S
    Res Initiat Treat Action; 1999 Jan; 5(1):9-10. PubMed ID: 11366234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.